Foot ulcerations in patients with diabetes are common. Most ulcers heal with conservative treatment, but recurrence is common. The pathway of ulcer development includes neuropathy, deformity, and trauma. The first attempt to avoid recurrence is by the use of shoes and insoles. When shoes and insoles fail, surgical correction of deformity leading to the ulcer can be attempted. This article reviews the most common procedures performed to heal ulcers or avoid recurrence.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2007. Atlanta, GA: Centers for Disease Control and Prevention; 2007.
2.
RonnemaaTHamalainenHToikkaTLiukkonenI. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care. 1997;20:1833-1837.
3.
PlankJHaasWRakovacI. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care. 2003;26:1691-1695.
4.
ArmstrongDGHarklessLB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg. 1998;37:460-466.
5.
LeeseGPStangDPearsonDW; Scottish Diabetes Foot Action Group. A national approach to diabetes foot risk stratification and foot care. Scott Med J. 2011;56:151-155.
6.
LaveryLAArmstrongDGWunderlichRPTredwellJBoultonAJ. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26:1069-1073.
7.
MargolisDJKantorJBerlinJA. Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta-analysis. Diabetes Care. 1999;22:692-695.
8.
PecoraroREReiberGEBurgessEM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513-521.
9.
ReiberGEVileikyteLBoykoEJ. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157-162.
10.
ArmstrongDGLaveryLA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am. 1998;80:365-369.
11.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.
12.
LaveryLAHarklessLBAshryHRFelder-JohnsonK. Infected puncture wounds in adults with diabetes: risk factors for osteomyelitis. J Foot Ankle Surg. 1994;33:561-566.
13.
LaveryLAArmstrongDGWunderlichRPMohlerMJWendelCSLipskyBA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288-1293.
14.
ArmstrongDGLaveryLAVazquezJR. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes. Diabetes Care. 2003;26:3284-3287.
15.
WinkleyKStahlDChalderTEdmondsMEIsmailK. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications. 2007;21:341-349.
16.
JeffcoateWJChipchaseSYIncePGameFL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29:1784-1787.
17.
DargisVPantelejevaOJonushaiteAVileikyteLBoultonAJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care. 1999;22:1428-1431.
18.
EdmondsMEBlundellMPMorrisMEThomasEMCottonLTWatkinsPJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med. 1986;60:763-771.
19.
UccioliLFagliaEMonticoneG. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care. 1995;18:1376-1378.
20.
LaveryLAPetersEJWilliamsJRMurdochDPHudsonALaveryDC. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008;31:154-156.
21.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67.
22.
MostazaJMSuarezCManzanoL. Sub-clinical vascular disease in type 2 diabetic subjects: relationship with chronic complications of diabetes and the presence of cardiovascular disease risk factors. Eur J Intern Med. 2008;19:255-260.
23.
FowkesFGHousleyECawoodEHMacintyreCCRuckleyCVPrescottRJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384-392.
24.
O’HareAMVittinghoffEHsiaJShlipakMG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol. 2004;15:1046-1051.
25.
RidkerPMStampferMJRifaiN. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481-2485.
26.
SentiMNoguesXPedro-BotetJRubies-PratJVidal-BarraquerF. Lipoprotein profile in men with peripheral vascular disease: role of intermediate density lipoproteins and apoprotein E phenotypes. Circulation. 1992;85:30-36.
27.
CriquiMHVargasVDenenbergJO. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112:2703-2707.
28.
MuntnerPWildmanRPReynoldsKDesalvoKBChenJFonsecaV. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care. 2005;28:1981-1987.
29.
SelvinEMarinopoulosSBerkenblitG. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421-431.
FowkesFGMurrayGDButcherI. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197-208.
32.
DickhautSCDeLeeJCPageCP. Nutritional status: importance in predicting wound-healing after amputation. J Bone Joint Surg Am. 1984;66:71-75.
33.
WagnerFWJr.Amputations of the foot and ankle: current status. Clin Orthop Relat Res. 1977;(122):62-69.
34.
PinzurMSStuckRMSageRHuntNRabinovichZ. Syme ankle disarticulation in patients with diabetes. J Bone Joint Surg Am. 2003;85-A:1667-1672.
35.
HirschATHaskalZJHertzerNR. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239-1312.
36.
BrilV. NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol. 1999;41(suppl 1):8-13.
37.
DyckPJMeltonLJIIIO’BrienPCServiceFJ. Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes. 1997;46(suppl 2):S5-S8.
38.
OlaleyeDPerkinsBABrilV. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract. 2001;54:115-128.
39.
ArmstrongDGLaveryLAVelaSAQuebedeauxTLFleischliJG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289-292.
40.
LaveryLAArmstrongDG. Temperature monitoring to assess, predict, and prevent diabetic foot complications. Curr Diab Rep. 2007;7:416-419.
41.
ArmstrongDGHoltz-NeidererKWendelCMohlerMJKimbrielHRLaveryLA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med. 2007;120:1042-1046.
42.
ReiberGESmithDGWallaceC. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA. 2002;287:2552-2558.
43.
NdipARutterMKVileikyteL. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care. 2010;33:1811-1816.
44.
LaveryLAHuntNALafontaineJBaxterCLNdipABoultonAJ. Diabetic foot prevention: a neglected opportunity in high-risk patients. Diabetes Care. 2010;33:1460-1462.
45.
RosenblumBIGiuriniJMChrzanJSHabershawGM. Preventing loss of the great toe with the hallux interphalangeal joint arthroplasty. J Foot Ankle Surg. 1994;33:557-560.
46.
ArmstrongDGLaveryLASternSHarklessLB. Is prophylactic diabetic foot surgery dangerous?J Foot Ankle Surg. 1996;35:585-589.
ArmstrongDGLaveryLAHarklessLB. Treatment-based classification system for assessment and care of diabetic feet. J Am Podiatr Med Assoc. 1996;86:311-316.
49.
BirkeJASimsDS. Plantar sensory threshold in the ulcerative foot. Lepr Rev. 1986;57:261-267.
50.
ArmstrongDGLaveryLAHarklessLB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21:855-859.
51.
GudasCJ. Prophylactic surgery in the diabetic foot. Clin Podiatr Med Surg. 1987;4:445-458.
52.
ArmstrongDGLaveryLAFrykbergRGWuSCBoultonAJ. Validation of a diabetic foot surgery classification. Int Wound J. 2006;3:240-246.
53.
BoffeliTJBeanJKNatwickJR. Biomechanical abnormalities and ulcers of the great toe in patients with diabetes. J Foot Ankle Surg. 2002;41:359-364.
54.
LabordeJM. Neuropathic toe ulcers treated with toe flexor tenotomies. Foot Ankle Int. 2007;28:1160-1164.
55.
LinSSBonoCMLeeTH. Total contact casting and Keller arthoplasty for diabetic great toe ulceration under the interphalangeal joint. Foot Ankle Int. 2000;21:588-593.
56.
DownsDMJacobsRL. Treatment of resistant ulcers on the plantar surface of the great toe in diabetics. J Bone Joint Surg Am. 1982;64:930-933.
57.
VallierGTPetersenSALaGroneMO. The Keller resection arthroplasty: a 13-year experience. Foot Ankle. 1991;11:187-194.
58.
StewartJReedJFIII. An audit of Keller arthroplasty and metatarsophalangeal joint arthrodesis from national data. Int J Low Extrem Wounds. 2003;2:69-73.
59.
ReiberGEBoykoEJSmithDG. Lower extremity foot ulcers and amputations in diabetes. In: HarrisMICowieCCSternMPBoykoEJReiberGEBennettPH, eds. Diabetes in America. 2nd ed.Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:409-428.
60.
SinghNArmstrongDGLipskyBA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-228.
61.
YoungMJBreddyJLVevesABoultonAJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17:557-560.
62.
BoykoEJAhroniJHStenselVForsbergRCDavignonDRSmithDG. A prospective study of risk factors for diabetic foot ulcer: The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-1042.
63.
TamirEMcLarenAMGadgilADanielsTR. Outpatient percutaneous flexor tenotomies for management of diabetic claw toe deformities with ulcers: a preliminary report. Can J Surg. 2008;51:41-44.
64.
LeungPC. Diabetic foot ulcers: a comprehensive review. Surgeon. 2007;5:219-231.
65.
McGlamryEDJimenezALGreenDR. Lesser ray deformities. In: BanksASDowneyMSMartinDEMillerSJeds. McGlamry’s Comprehesive Textbook of Foot and Ankle Surgery. 3rd ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2001:268-269.
66.
PadanilamTG. The flexible hammer toe flexor-to-extensor transfer. Foot Ankle Clin. 1998;3:259-267.
67.
SchrierJCVerheyenCCLouwerensJW. Definitions of hammer toe and claw toe: an evaluation of the literature. J Am Podiatr Med Assoc. 2009;99:194-197.
68.
KearneyTPHuntNALaveryLA. Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes. Diabetes Res Clin Pract. 2010;89:224-226.
69.
Rou’kisTSSchadeVL. Percutaneous flexor tenotomy for treatment of neuropathic toe ulceration secondary to toe contracture in persons with diabetes: a systematic review. J Foot Ankle Surg. 2009;48:684-689.
70.
KimJYKimTWParkYELeeYJ. Modified resection arthroplasty for infected non-healing ulcers with toe deformity in diabetic patients. Foot Ankle Int. 2008;29:493-497.
71.
MuellerMJMinorSDDiamondJEBlairVPIII. Relationship of foot deformity to ulcer location in patients with diabetes mellitus. Phys Ther. 1990;70:356-362.
72.
MuellerMJHastingsMCommeanPK. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36:1009-1017.
73.
GriffithsGDWiemanTJ. Metatarsal head resection for diabetic foot ulcers. Arch Surg. 1990;125:832-835.
RosenblumBIPomposelliFBJrGiuriniJM. Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes: a 5-year experience. Diabetes Care. 1994;17:983-987.
76.
GiuriniJMBasilePChrzanJSHabershawGMRosenblumBI. Panmetatarsal head resection: a viable alternative to the transmetatarsal amputation. J Am Podiatr Med Assoc. 1993;83:101-107.
77.
LaveryLAArmstrongDGBoultonAJ. Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. J Am Podiatr Med Assoc. 2002;92:479-482.
78.
MuellerMJSinacoreDRHastingsMKStrubeMJJohnsonJE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers: a randomized clinical trial. J Bone Joint Surg Am. 2003;85-A:1436-1445.
79.
GrantWPSullivanRSonenshineDE. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36:272-278; discussion 330.
80.
BatistaFNeryCPinzurM. Achilles tendinopathy in diabetes mellitus. Foot Ankle Int. 2008;29:498-501.
81.
RosenthalAKGohrCMMittonEMonnierVBurnerT. Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes. J Investig Med. 2009;57:460-466.
82.
ReddyGK. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues. J Orthop Res. 2003;21:738-743.
83.
DiGiovanniCWKuoRTejwaniN. Isolated gastrocnemius tightness. J Bone Joint Surg Am. 2002;84-A:962-970.
84.
MortonDJ. The Human Foot. New York, NY: Columbia University Press; 1935.
85.
MichaelSD. Ankle equinus. In: BanksASDowneyMSMartinDEMillerSJeds. McGlamry’s Comprehensive Textbook of Foot and Ankle Surgery. Vol 1, 3rd ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2001:715-760.
86.
HolsteinPLohmannMBitschMJorgensenB. Achilles tendon lengthening, the panacea for plantar forefoot ulceration?Diabetes Metab Res Rev. 2004;20(suppl 1):S37-S40.
87.
ArmstrongDGStacpoole-SheaSNguyenHHarklessLB. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am. 1999;81:535-538.
88.
BarryDCSabacinskiKAHabershawGMGiuriniJMChrzanJS. Tendo Achillis procedures for chronic ulcerations in diabetic patients with transmetatarsal amputations. J Am Podiatr Med Assoc. 1993;83:96-100.
89.
La FontaineJBrownDAdamsMVanPeltM. New and recurrent ulcerations after percutaneous achilles tendon lengthening in transmetatarsal amputation. J Foot Ankle Surg. 2008;47:225-229.
90.
ArmstrongDGLaveryLAKimbrielHRNixonBPBoultonAJ. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care. 2003;26:2595-2597.
91.
BowlingFLMetcalfeSAWuSBoultonAJArmstrongDG. Liquid silicone to mitigate plantar pedal pressure: a literature review. J Diabetes Sci Technol. 2010;4:846-852.
92.
van SchieCHWhalleyAArmstrongDGVileikyteLBoultonAJ. The effect of silicone injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: a 2-year follow-up. Arch Phys Med Rehabil. 2002;83:919-923.
93.
van SchieCHWhalleyAVileikyteLWignallTHollisSBoultonAJ. Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:634-638.
94.
BalkinSW. Silicone injection for plantar keratoses: preliminary report. J Am Podiatry Assoc. 1966;56:1-11.
95.
BalkinSW. Treatment of painful scars on soles and digits with injections of fluid silicone. J Dermatol Surg Oncol. 1977;3:612-614.
